Vertical: CNMBase Year: 2025
Market Size (2025)
$736.51M
Projected (2032)
$935.68M
CAGR (2022–2032)
4.1%
Key Players
10+
Market Overview
The global diethanolamide market was valued at USD 736.52 Million in 2025 and is projected to reach USD 935.68 Million by 2032, expanding at a CAGR of 3.36% during 2026–2032. The market grew from USD 624.69 Million in 2022, and is expected to add USD 199.16 Million in absolute value between 2025 and 2032. Diethanolamides, led by coconut diethanolamide (cocamide DEA), are non-ionic surfactants used as foam boosters, viscosity builders, emulsifiers and corrosion inhibitors in personal care products, household cleaners and a broad range of industrial formulations.
The market's steady expansion reflects the essential and cost-effective role of diethanolamides in surfactant-based formulations, rising consumption of liquid personal care and cleaning products in emerging economies, and continued use in metalworking fluids, textile auxiliaries and industrial cleaners. Growth is moderated by regulatory scrutiny of diethanolamine-derived ingredients, substitution in premium personal care and the volatility of coconut oil feedstock prices.
Key Findings
Product Type: Coconut Diethanolamide is the largest segment, holding 70.00% of the market in 2025 (USD 515.56 Million), while Others is the fastest-growing segment, with a CAGR of 4.10% over 2026–2032.
Application: Personal Care is the largest application, with a 50.00% share in 2025 (USD 368.26 Million), while Household Cleaning is the fastest-growing application, with a CAGR of 3.94%.
Region: Asia Pacific is the leading region, accounting for 45.00% of global value in 2025 (USD 331.43 Million), while Middle East & Africa is the fastest-growing region, with a CAGR of 4.04%.
Country: China is the leading country market, valued at USD 139.20 Million in 2025, followed by the U.S. at USD 111.95 Million. The UAE is the fastest-growing country, with a CAGR of 4.85%, followed by India at 4.66%.
Segmentation Summary
By product type, Coconut Diethanolamide dominates owing to the favourable C12–C14 chain distribution of coconut fatty acids, which delivers strong foam boosting and thickening with anionic surfactants. The segment is projected to grow from USD 515.56 Million in 2025 to USD 640.57 Million in 2032 at a CAGR of 3.04%. The Others segment, covering diethanolamides from lauric, oleic, stearic, palm kernel, soybean and tall oil fatty acids, is projected to grow from USD 220.95 Million to USD 295.11 Million, supported by feedstock diversification and industrial applications.
By application, Personal Care remains the largest outlet, growing from USD 368.26 Million in 2025 to USD 452.12 Million in 2032 at a CAGR of 2.86%. Household Cleaning, valued at USD 220.95 Million in 2025, and Industrial & Others, valued at USD 147.30 Million, are forecast to grow faster, at 3.94% and 3.72% respectively, as liquid cleaning products spread in emerging markets and industrial demand expands in Asia.
Regionally, Asia Pacific is projected to add USD 98.14 Million between 2025 and 2032, the largest absolute gain of any region, reaching USD 429.57 Million. Europe (USD 162.03 Million in 2025) and North America (USD 147.30 Million) are mature markets growing at 2.84% and 2.84% respectively, while Latin America (3.94%) and the Middle East & Africa (4.04%) are the fastest-growing regions from smaller bases.
Competitive Landscape Summary
The market is moderately fragmented, combining multinational surfactant and oleochemical producers with a large base of regional suppliers in Asia. Stepan Company, Kao Corporation, BASF SE and Indorama Ventures (Indovinya) are positioned as market leaders on the strength of their broad alkanolamide portfolios, integrated feedstock chains and global customer relationships. Evonik Industries, Innospec, Galaxy Surfactants, KLK OLEO and Syensqo are key challengers, while Croda International participates as a niche supplier. Since 2022, leading companies have focused on acquisitions, capacity expansions in alkoxylation, amines and oleochemicals, partnerships with major consumer goods companies and the development of bio-based surfactants.
Challenges and Opportunities
The market's principal challenges are regulatory and reputational. The classification of coconut oil diethanolamine condensate as possibly carcinogenic to humans by IARC, its listing under California Proposition 65 and restrictions on fatty acid dialkanolamides under the EU Cosmetics Regulation have led many brand owners in mature markets to reformulate with alternative ingredients. Substitution by cocamide MEA, betaines and alkyl polyglucosides, together with record coconut oil prices in 2025, adds further pressure on demand and margins.
At the same time, the market offers clear opportunities. Low-impurity superamide grades can sustain use in regulated markets; diversified and sustainably sourced feedstocks support the faster-growing Others segment; and rising consumption of liquid household cleaners and personal care products in India, Southeast Asia, Brazil and the Gulf states provides a long runway for volume growth.
Future Outlook
The diethanolamide market is expected to follow a stable growth path through 2032, increasing from USD 767.18 Million in 2026 to USD 935.68 Million in 2032. Demand will continue to shift geographically towards Asia Pacific, Latin America and the Middle East & Africa, and functionally towards household cleaning and industrial uses. Producers that combine secure lauric oil feedstock access, high-purity product grades, sustainable sourcing credentials and strong regional distribution are best positioned to capture this growth.
The Diethanolamide Market market is projected to grow at a CAGR of 4.1% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Diethanolamides are non-ionic surfactants formed by the condensation of fatty acids, fatty acid methyl esters or natural triglycerides with diethanolamine (DEA). The reaction yields an alkanolamide with a hydrophobic fatty acyl chain and a hydrophilic bis(2-hydroxyethyl) amide head group. Two commercial grades dominate: 1:1 "superamides", typically produced from methyl esters and characterised by high amide content and low free amine, and 2:1 "Kritchevsky" amides, produced from fatty acids with a molar excess of diethanolamine, which offer higher water solubility but contain residual free amine and amine soaps.
In formulated products, diethanolamides act as foam boosters and foam stabilisers, viscosity builders, emulsifiers, wetting agents, superfatting agents, solubilisers and corrosion inhibitors. They are used at low inclusion levels, generally alongside anionic surfactants such as sodium laureth sulfate and linear alkylbenzene sulfonate, where they thicken the formulation and stabilise lather.
The market studied in this report covers the merchant value of fatty acid diethanolamides sold to formulators, measured at the manufacturer level. It is segmented by product type into Coconut Diethanolamide (cocamide DEA, derived from coconut oil fatty acids or their methyl esters) and Others, the latter covering diethanolamides based on other fatty acid feedstocks such as lauric, oleic, stearic, palm kernel, soybean and tall oil fatty acids.
Included: fatty acid diethanolamides of both 1:1 and 2:1 type, supplied as neat amides or as commercial blends in which the amide is the principal active component, for personal care, household cleaning, industrial and other applications.
Excluded: diethanolamine itself sold as an amine intermediate; monoethanolamides (such as cocamide MEA) and monoisopropanolamides (such as cocamide MIPA); ethoxylated alkanolamides; amphoteric surfactants such as betaines; and the value of finished consumer or industrial products in which diethanolamides are incorporated.
Scope of the Study
The study quantifies the global diethanolamide market in value terms and analyses it across three segmentations, reproduced exactly as defined in the underlying market model:
By Product Type: Coconut Diethanolamide; Others
By Application: Personal Care; Household Cleaning; Industrial & Others
By Region: North America; Europe; Asia Pacific; Latin America; Middle East & Africa, with country-level analysis for the countries listed in the market structure below
The study timeline comprises historic years 2022, 2023 and 2024, the base year 2025 and the forecast period 2026–2032. Growth rates are expressed as the compound annual growth rate (CAGR) for 2026–2032. All market values are presented in USD Million.
Research Objectives
To estimate the size of the global diethanolamide market for the historic years 2022–2024 and the base year 2025, and to forecast its value through 2032.
To analyse the market by product type, distinguishing coconut-based diethanolamide from diethanolamides derived from other fatty acid feedstocks.
To evaluate demand across personal care, household cleaning and industrial and other applications, and to identify the formulation trends shaping each.
To assess regional and country-level demand patterns across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
To examine the regulatory environment for diethanolamides, including carcinogen listings, nitrosamine controls and cosmetic ingredient restrictions, and to assess its effect on substitution and reformulation.
To analyse the influence of coconut oil, palm kernel oil and diethanolamine supply and pricing on producer economics.
To identify drivers, restraints, opportunities, trends and challenges influencing the market over 2026–2032.
To profile the competitive landscape and track strategic developments by leading producers since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process combining secondary research, primary research and quantitative modelling. The process began with defining the product scope and segmentation, followed by the collection of production, trade, pricing and consumption information for diethanolamides and their principal feedstocks. These inputs were used to construct a bottom-up demand model and a top-down supply model, which were reconciled through data triangulation. Market estimates and qualitative findings were then validated through discussions with industry participants across the value chain before the forecast was finalised.
The research process comprised the following stages:
Definition of the market, product types, applications and geographic coverage
Secondary research to build a baseline of supply, demand, trade and pricing information
Primary research with supply-side and demand-side participants to validate assumptions
Market size estimation using top-down and bottom-up approaches, followed by triangulation
Forecasting based on demand drivers, end-use growth and regulatory and feedstock factors
Internal quality review of segment, regional and country consistency
Secondary Research
Secondary research was used to establish the baseline understanding of the diethanolamide industry, its feedstocks and its end-use markets. The sources consulted were selected for their relevance to oleochemicals, surfactants and the personal care and household cleaning industries:
Industry associations: surfactant and detergent associations such as the European Committee of Organic Surfactants and their Intermediates (CESIO), the American Cleaning Institute (ACI), the International Association for Soaps, Detergents and Maintenance Products (A.I.S.E.), Cosmetics Europe, the Personal Care Products Council and national oleochemical and coconut industry bodies.
Government and regulatory bodies: chemical and cosmetic regulators including the European Chemicals Agency (ECHA), the European Commission's CosIng database, the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration, California's Office of Environmental Health Hazard Assessment (OEHHA), Health Canada, the International Agency for Research on Cancer (IARC) and national statistical and trade offices.
Company filings: annual reports, investor presentations, sustainability reports and product literature of surfactant and oleochemical producers.
Trade journals and publications: chemical industry and personal care trade press covering surfactant capacity, feedstock markets and formulation trends.
Paid databases and trade statistics: international trade databases for organic surface-active agents and fatty acid amides, oleochemical price reporting services and company information databases.
Primary Research
Primary research was conducted to validate the secondary findings, fill information gaps and obtain forward-looking perspectives on demand, pricing and regulation. In-depth interviews were carried out with participants on both the supply side and the demand side of the market.
Supply-side respondents: senior executives, business heads, product managers, sales and marketing managers and technical service specialists at diethanolamide and alkanolamide producers, oleochemical and fatty acid suppliers, diethanolamine producers and chemical distributors.
Demand-side respondents: formulation chemists, procurement managers and R&D leads at personal care, household cleaning, institutional cleaning, metalworking fluid and textile auxiliary manufacturers, together with contract manufacturers.
Industry experts: independent consultants, regulatory affairs specialists and trade association representatives.
The objectives of primary research were to verify market size and segment splits, understand pricing dynamics and feedstock pass-through, assess the pace of substitution by alternative amides and amphoteric surfactants, gauge regional demand outlooks and capture recent strategic developments.
Market Size Estimation
Bottom-up approach: Demand was estimated at the country level by application. Consumption of diethanolamides in personal care, household cleaning and industrial and other applications was derived from the output of the relevant end products, typical diethanolamide inclusion rates in each formulation category and the penetration of diethanolamides relative to alternative foam boosters and thickeners. Country volumes were converted into value using regional average selling prices, then aggregated to regional and global totals.
Top-down approach: The global market was also estimated from the supply side, using the diethanolamide-related revenues and estimated production of leading alkanolamide and surfactant producers, adjusted for captive consumption and trade flows. The global total was then allocated across product types, applications, regions and countries using shares derived from secondary and primary research.
Data triangulation: The results of the bottom-up and top-down approaches were compared and reconciled. Where differences arose, the underlying assumptions on inclusion rates, prices and producer shares were re-examined and validated with industry participants until the two approaches converged on a consistent estimate.
Forecasting Methodology
The forecast for 2026–2032 was developed by projecting demand in each application and country and applying expected price developments. The principal factors considered were:
Growth in the production and consumption of shampoos, body washes, liquid hand soaps, hand dishwashing liquids and liquid household cleaners
Industrial output in metalworking, textiles and other end uses employing diethanolamides
Population growth, urbanisation and rising disposable income in emerging economies
Regulatory developments affecting the use of diethanolamides, particularly carcinogen listings, nitrosamine controls and cosmetic ingredient restrictions
Substitution by monoethanolamides, monoisopropanolamides, betaines and alkyl polyglucosides
Coconut oil, palm kernel oil and diethanolamine price trends and their pass-through to amide prices
A combination of time-series analysis, regression against end-use indicators and expert judgement was used. Forecasts were reviewed for internal consistency so that product type, application, regional and country results reconcile to the global total in each year.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
Growth metric: compound annual growth rate (CAGR) for 2026–2032
Currency: USD Million, at constant exchange rates
Assumptions and Limitations
Market values are expressed at the manufacturer selling-price level and exclude distributor margins and the value of finished formulations.
Exchange rates are held constant for the forecast period, so currency movements do not affect the forecast values.
Regulatory frameworks in force in 2025 are assumed to remain broadly in place, with no outright prohibition of diethanolamides in household or industrial applications in major markets during the forecast period.
Feedstock prices are assumed to normalise from the elevated levels seen in the base year without a prolonged supply disruption in coconut-producing countries.
No major macroeconomic shock comparable to the COVID-19 pandemic is assumed during the forecast period.
Because diethanolamides are frequently traded within broader customs classifications for surface-active agents and amides, trade data cannot isolate diethanolamides precisely, and country estimates rely on modelled allocations validated through primary research.
Captive consumption by integrated producers is estimated where it is not separately disclosed.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global diethanolamide market is moderately fragmented. A group of multinational surfactant and oleochemical producers with broad alkanolamide ranges and global customer relationships competes alongside a large number of regional producers, particularly in China, India and Southeast Asia, that supply commodity grades to local formulators. No single producer dominates, and diethanolamides typically form part of a broader foam booster and amide portfolio that also includes monoethanolamides, monoisopropanolamides and betaines.
Competition centres on price, product purity, consistency of supply, technical service and regulatory support. Because diethanolamides are relatively standardised, producers differentiate through low-free-amine superamide grades, feedstock integration and sustainable sourcing credentials, the breadth of their alternative surfactant portfolios, and their ability to support customers in reformulation. Leading producers have pursued acquisitions, capacity expansions and partnerships with major consumer goods companies since 2022, with an increasing emphasis on bio-based and sustainably sourced surfactants.
Key Player Positioning
Based on the breadth of their diethanolamide and alkanolamide ranges, surfactant scale, geographic reach and customer relationships, the leading companies can be grouped into three categories:
Leaders: Stepan Company, Kao Corporation, BASF SE and Indorama Ventures (Indovinya)
Challengers: Evonik Industries, Innospec Inc., Galaxy Surfactants Ltd, KLK OLEO and Syensqo SA
Niche players: Croda International Plc
Stepan Company
Stepan Company, headquartered in Northbrook, Illinois, United States, and founded in 1932, is one of the world's largest producers of anionic and non-ionic surfactants, with its Surfactants segment serving consumer cleaning, personal care and industrial markets. The company reported net sales of USD 2,332.1 million for FY2025, of which the Surfactants segment contributed USD 1,666.0 million. Its diethanolamide offering is marketed under the NINOL brand, including NINOL 40-CO and NINOL 49-CE (cocamide DEA). Stepan's strategy focuses on scale and cost leadership in surfactants, growth in higher-value alkoxylates on the U.S. Gulf Coast and site rationalisation to restore margins. Its strong position with North American home care and personal care customers places it among the market leaders.
Kao Corporation
Kao Corporation, headquartered in Tokyo, Japan, and founded in 1887, combines a consumer products business with a global chemical business spanning fatty alcohols, amines, surfactants and performance chemicals, with production in Japan, Southeast Asia, Europe and the Americas. Kao reported consolidated net sales of approximately JPY 1,688.6 billion for FY2025. Its diethanolamide products include AMIDET KDE, a coconut oil fatty acid diethanolamide produced in the EU. Kao's strategy leverages its integrated oleochemical value chain to supply surfactants globally, while diversifying feedstocks through biotechnology partnerships and localising production close to customers.
BASF SE
BASF SE, headquartered in Ludwigshafen, Germany, and founded in 1865, is the world's largest chemical company by sales. Its Care Chemicals business supplies surfactants, emollients and actives to personal care, home care and industrial formulators. BASF reported group sales of EUR 59,657 million for FY2025. Its COMPERLAN amide range includes COMPERLAN COD and COMPERLAN KD (cocamide DEA), COMPERLAN LD (lauramide DEA) and COMPERLAN OD-V (oleamide DEA), reflecting one of the broadest diethanolamide portfolios in the market. BASF's strategy draws on its integrated Verbund production, including ethylene oxide and fatty alcohols, while investing in regional capacity and bio-based surfactants such as alkyl polyglucosides.
Indorama Ventures (Indovinya)
Indorama Ventures, headquartered in Bangkok, Thailand, operates its surfactants and specialty chemicals business under the Indovinya brand, built around Oxiteno, which it acquired in 2022. Indovinya operates 15 plants and seven R&D centres in ten countries and is a leading surfactant producer in the Americas. Indorama Ventures reported revenue from the sale of goods of THB 447,246 million for FY2025. Its diethanolamide products include ALKOLAN COD 90 and ALKOLAN CODG 80 (cocamide DEA) and ALKOLAN CD 80 and CD 90 (palm kernelamide DEA). The company's strategy rests on an integrated ethylene oxide-to-surfactants chain in the Americas, complemented by bolt-on specialty acquisitions.
Evonik Industries
Evonik Industries, headquartered in Essen, Germany, is a specialty chemicals group whose care and household care businesses supply surfactants, conditioning agents, biosurfactants and actives, building on the Goldschmidt and Rewo surfactant heritage. Evonik reported sales of EUR 14.1 billion for FY2025. Its diethanolamide range includes REWOMID DC 212 S (cocamide DEA) for personal care and REWOMID DC 212 for industrial cleaning and corrosion inhibition. Evonik is shifting its care portfolio towards bio-based and biodegradable surfactants such as rhamnolipids, while maintaining its established amides for industrial and personal care uses.
Innospec Inc.
Innospec Inc., headquartered in Englewood, Colorado, United States, operates through Performance Chemicals, Fuel Specialties and Oilfield Services segments and acquired Huntsman's European surfactants business, including the EMPILAN brand, in 2016. The company reported total revenues of USD 1,778.0 million for FY2025, including USD 681.4 million from Performance Chemicals. Its alkanolamide range includes EMPILAN 2502 (cocamide DEA) alongside monoethanolamide and monoisopropanolamide grades. Innospec's strategy focuses on mild and sulfate-free specialty surfactants, bolt-on acquisitions and margin improvement in Performance Chemicals.
Galaxy Surfactants Ltd
Galaxy Surfactants, headquartered in Navi Mumbai, India, and founded in 1980, is a major supplier of performance surfactants and specialty care ingredients to home and personal care companies, serving more than 1,450 customers in over 80 countries from plants in India, Egypt and the United States. The company reported revenue of approximately INR 52.5 billion for the financial year ended March 2026. Its foam and viscosity boosters include Galaxy 110 and Galaxy 111 (cocamide DEA). Galaxy's strategy combines low-cost, high-volume performance surfactants with a shift towards specialty care, supported by close partnerships with multinational customers.
KLK OLEO
KLK OLEO is the oleochemical division of Kuala Lumpur Kepong Berhad, headquartered in Malaysia, and is one of the largest palm-based oleochemical producers, with operations in Malaysia, Indonesia, China and Europe. KLK Group reported revenue of approximately MYR 25.0 billion for the financial year ended September 2025. Its PALMOCOL alkanolamide range includes cocamide DEA for cleaning applications. KLK OLEO's backward integration into plantations provides a feedstock advantage, and its strategy focuses on expanding downstream specialty products in Asia and Europe based on sustainable palm-derived ingredients.
Syensqo SA
Syensqo, headquartered in Brussels, Belgium, became an independent listed company following its separation from Solvay in December 2023. Its Novecare business supplies surfactants and formulated solutions to home and personal care, agrochemical, coatings and industrial markets. Syensqo reported net sales of EUR 6,140 million for FY2025. Its ALKAMIDE range is among the broadest in the market, covering ALKAMIDE DC-212/S and ALKAMIDE KD (cocamide DEA), ALKAMIDE LE and DL-207-S (lauramide DEA), ALKAMIDE DO-280 (oleamide DEA) and ALKAMIDE DIN 295-S (soyamide DEA). The company's strategy concentrates on core specialty businesses and on sustainable, bio-circular and mass-balance surfactants.
Croda International Plc
Croda International, headquartered in Snaith, United Kingdom, and founded in 1925, is a specialty chemicals company focused on Consumer Care and Life Sciences following the divestment of most of its industrial chemicals business in 2022. Croda reported group sales of GBP 1,699.4 million for FY2025, including GBP 972.7 million from Consumer Care. Its INCROMIDE alkanolamide range includes INCROMIDE CDEA (cocamide DEA), which forms a small part of a high-value specialty portfolio. Croda's strategy prioritises high-margin actives, fragrances and expansion of its manufacturing footprint in Asia, positioning it as a niche participant in diethanolamides.
Competitor Dashboard
The dashboard below rates each profiled company on four competitive parameters relevant to the diethanolamide market.
Threat of New Entrants: Medium
Manufacturing technology is well established and can be operated in multipurpose batch plants, so technical barriers are moderate.
Access to competitively priced lauric oil feedstocks and diethanolamine, and the need for customer qualification, quality systems and regulatory documentation, favour established producers.
Regional entrants in Asia and the Middle East can compete in commodity grades, but face difficulty winning multinational accounts.
Bargaining Power of Suppliers: High
Coconut oil supply is concentrated in a few producing countries and is exposed to weather and crop cycles, giving feedstock suppliers significant pricing influence.
Diethanolamine is produced by a limited number of large petrochemical companies, and its price follows ethylene oxide costs.
Non-integrated amide producers have limited ability to pass on feedstock increases immediately under contract pricing.
Bargaining Power of Buyers: High
Large multinational personal care and home care companies purchase significant volumes and run competitive tenders across multiple qualified suppliers.
Diethanolamides are relatively standardised products, which makes switching between suppliers feasible once qualified.
Buyers can reduce inclusion rates or reformulate with alternative ingredients, strengthening their negotiating position.
Threat of Substitutes: High
Cocamide MEA, cocamide MIPA, cocamidopropyl betaine, alkyl polyglucosides and amine oxides offer comparable foam and viscosity functions.
Regulatory listings and "DEA-free" marketing claims encourage substitution in personal care.
Substitutes are often more costly or harder to handle, which limits substitution in household and industrial applications.
Competitive Rivalry: Medium to High
The market includes multinational surfactant producers, integrated oleochemical companies and numerous regional suppliers competing largely on price, quality and service.
Moderate overall growth and product standardisation intensify price competition in commodity grades.
Differentiation through high-purity grades, sustainable sourcing and technical service softens rivalry in higher-value segments.
Threat of New Entrants: Medium; Mature technology offset by feedstock access, qualification and regulatory requirements.
Bargaining Power of Suppliers: High; Concentrated coconut oil and diethanolamine supply with volatile pricing.
Bargaining Power of Buyers: High; Large consolidated buyers, standardised products and ability to reformulate.
Threat of Substitutes: High; Wide range of alternative amides, betaines and glucosides, reinforced by regulation.
Competitive Rivalry: Medium to High; Many suppliers, moderate growth and price competition in commodity grades.
Market estimates by geography (2032)
InsightAsia Pacific leads with $429.57M by 2032, while Middle East & Africa is projected to grow fastest at a 4.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $126.44M | $158.02M | $180.59M | 3.6% | 19% |
| Europe | $139.08M | $173.82M | $198.64M | 3.6% | 21% |
| Asia Pacific | $279.16M | $361.21M | $429.57M | 4.4% | 46% |
| Latin America | $43.13M | $56.50M | $68.12M | 4.7% | 7% |
| Middle East & Africa | $36.88M | $48.52M | $58.76M | 4.8% | 6% |
| Total | $624.69M | $798.07M | $935.68M | 4.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$935.68M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Coconut Diethanolamide | $640.57M | 3.8% | 68% |
| Others | $295.11M | 4.8% | 32% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Diethanolamide Market covering market dynamics, competitive landscape, and strategic outlook.
The Diethanolamide Market market is projected to reach $935.68M by 2032, growing at 4.1% CAGR. The Coconut Diethanolamide segment holds the largest share.
The global diethanolamide market is a mature but steadily expanding segment of the non-ionic surfactants industry. Valued at USD 736.52 Million in 2025, the market is projected to reach USD 935.68 Million by 2032, registering a CAGR of 3.36% during 2026–2032. Demand is anchored in the functional role of diethanolamides as low-cost, highly effective foam boosters and viscosity builders, while growth is moderated by regulatory scrutiny of diethanolamine-derived ingredients and by substitution in premium personal care formulations.
The balance of these forces differs by application and geography. Household cleaning and industrial uses, where diethanolamides remain the most cost-effective thickening and foam-stabilising option, are expanding faster than personal care, and emerging markets in Asia Pacific, Latin America and the Middle East & Africa are growing faster than mature markets in North America and Europe. Feedstock economics, particularly the price of coconut oil and diethanolamine, shape producer margins and pricing throughout the period.
Market Growth Factor Analysis
The table below summarises the principal macro and micro factors influencing the market, their impact type and their relative strength over three phases of the forecast period. The impact scores, on a scale of 1 (low) to 10 (high), are analyst assessments based on secondary research and industry interviews, and indicate the intensity of each factor's influence on market growth during each phase.
Growing Consumption of Liquid Household Cleaning Products
Household cleaning is the fastest-growing application in the market, rising from USD 220.95 Million in 2025 to USD 291.84 Million in 2032 at a CAGR of 3.94%. Diethanolamides are widely used in hand dishwashing liquids, all-purpose cleaners, floor and surface cleaners and liquid laundry products, where they build viscosity, stabilise foam in the presence of grease and improve the cleaning performance of anionic surfactant systems. Consumer preference in emerging markets continues to shift from bar soaps and powders towards liquid formats, which typically require thickeners and foam stabilisers. Urbanisation, the expansion of modern retail and rising household incomes in China, India, Southeast Asia, Brazil and the Gulf states are increasing per-capita use of dishwashing liquids and surface cleaners. Heightened hygiene awareness since the COVID-19 pandemic has also sustained higher baseline consumption of cleaning products in many markets. Because diethanolamides are less exposed to cosmetic ingredient restrictions in household formulations and deliver strong performance at low cost, formulators of mass-market cleaning products continue to rely on them, supporting volume growth throughout the forecast period.
Expanding Personal Care Markets in Emerging Economies
Personal care remains the largest application, accounting for 50.00% of market value in 2025, equivalent to USD 368.26 Million. Shampoos, body washes, liquid hand soaps and bubble baths are the core outlets, with diethanolamides used to boost lather, adjust viscosity and provide a conditioning skin feel. Although regulatory pressure has encouraged reformulation in North America and Europe, demand in Asia Pacific, Latin America and the Middle East & Africa continues to grow with population, urbanisation and spending on hygiene and grooming products. India's personal care segment is forecast to expand at 4.22% over 2026–2032, well above the global personal care rate of 2.86%. In price-sensitive mass-market products, which dominate volumes in these regions, cocamide DEA's combination of low cost, ease of formulation and reliable thickening with sodium laureth sulfate gives it an entrenched position. Regional and local brand owners and contract manufacturers in particular continue to specify diethanolamides, supporting sustained demand growth.
Functional Versatility and Cost-Effectiveness in Formulations
Diethanolamides offer a combination of properties that few alternative ingredients match at comparable cost. A single ingredient can boost and stabilise foam, build viscosity through its interaction with anionic surfactants and electrolyte, emulsify oils, solubilise fragrances and improve wetting. This multifunctionality allows formulators to simplify recipes and reduce the inclusion of more expensive specialty ingredients. Diethanolamides are liquid at room temperature in most grades, which eases handling in cold-process manufacturing compared with solid monoethanolamides that require melting. In industrial applications, the same molecules serve as corrosion inhibitors, lubricity additives and emulsifiers in water-miscible metalworking fluids, and as wetting and softening agents in textile processing. The Industrial & Others application, valued at USD 147.30 Million in 2025, is projected to grow at 3.72% through 2032, supported by these technical advantages. As inflation and cost pressures persist across consumer goods, the value proposition of diethanolamides continues to support their use in value-tier formulations.
Expansion of Oleochemical Capacity in Asia Pacific
Asia Pacific accounts for 45.00% of global market value in 2025, supported by the region's position as the centre of global lauric oil production. The Philippines and Indonesia are the world's largest coconut oil producers, and Indonesia and Malaysia dominate palm kernel oil supply, giving regional producers integrated access to C12–C14 fatty acids and methyl esters. Oleochemical producers in Malaysia, Indonesia, China and India have invested in fatty acid, fatty alcohol and specialty surfactant capacity, while surfactant producers have expanded alkanolamide output close to fast-growing consumer markets. This regional supply base shortens supply chains, lowers logistics costs for formulators and enables competitive pricing for export markets in the Middle East, Africa and Latin America. Investments by multinational personal care and home care companies in Asian manufacturing further localise demand. Together, these factors are expected to drive the Asia Pacific market from USD 331.43 Million in 2025 to USD 429.57 Million in 2032.
Low-Impurity and High-Purity Grades
Producers that can supply 1:1 superamide grades with very low free diethanolamine and controlled nitrosamine content are well placed to retain customers in regulated markets. Such grades can be specified in formulations that comply with EU cosmetic restrictions and allow formulators in industrial and household applications to meet tightening product stewardship requirements while preserving diethanolamide performance.
Bio-Based and Sustainably Sourced Feedstocks
Growing demand for traceable, renewable ingredients creates an opportunity for diethanolamides produced from certified sustainable palm kernel oil, traceable coconut oil and alternative fatty acids. The Others product segment, which includes diethanolamides based on non-coconut feedstocks, is projected to grow at 4.10%, faster than coconut diethanolamide at 3.04%, reflecting feedstock diversification and specialty applications.
Growth in Emerging Markets and Institutional Cleaning
The Middle East & Africa and Latin America are the fastest-growing regions, with CAGRs of 4.04% and 3.94% respectively. Expanding local manufacturing of detergents and personal care products in the Gulf states, Brazil, India and Southeast Asia, combined with growth in institutional and industrial cleaning, offers producers opportunities to establish regional supply partnerships and distribution networks.
Regulatory Scrutiny and Health Concerns
Regulatory and toxicological scrutiny is the most significant restraint on the market. Coconut oil diethanolamine condensate has been classified by the International Agency for Research on Cancer as possibly carcinogenic to humans (Group 2B), and in 2012 California listed it under Proposition 65 as a chemical known to the State to cause cancer, triggering warning requirements and enforcement actions against consumer products containing it. In the European Union, fatty acid dialkanolamides are restricted under the Cosmetics Regulation, with limits on secondary amine and nitrosamine content and a prohibition on use with nitrosating systems, owing to the potential for nitrosamine formation from residual diethanolamine. These measures have prompted many multinational brand owners to remove cocamide DEA from personal care products sold in North America and Europe, contributing to the slower growth of personal care demand in those regions.
Substitution by Alternative Foam Boosters and Thickeners
Diethanolamides face competition from a range of alternative ingredients, including cocamide MEA, cocamide MIPA, cocamidopropyl betaine, alkyl polyglucosides, amine oxides and polymeric and associative thickeners. Formulators seeking "DEA-free" claims, milder profiles or bio-based certification are increasingly adopting these alternatives, particularly in premium and natural personal care. Although these substitutes are often more expensive or more difficult to handle, their adoption limits diethanolamide demand growth in personal care, which is forecast at 2.86%, the lowest rate among the three applications.
Feedstock Price Volatility
Coconut oil is the principal feedstock for the largest product segment, and its price is exposed to weather, crop cycles and ageing tree stocks in the Philippines and Indonesia. Coconut oil prices rose to record levels in 2025 amid tight supply, while palm kernel oil, the main substitute lauric oil, has been affected by Indonesian biodiesel mandates and export policy. Diethanolamine prices follow ethylene oxide and ammonia costs. Such volatility squeezes producer margins, complicates contract pricing and can prompt formulators to reduce inclusion rates or switch to alternative ingredients.
Shift Towards "DEA-Free" Claims in Premium Personal Care
Brand owners in North America and Europe increasingly market personal care products as free of DEA and DEA-derived ingredients. This trend is shifting diethanolamide demand in these regions towards household, industrial and value-tier personal care products, a pattern reflected in personal care CAGRs of 2.27% in North America and 2.32% in Europe.
Feedstock Diversification Away from Coconut Oil
Producers are broadening their use of non-coconut fatty acids, including palm kernel, oleic, soybean and tall oil fatty acids, to manage price risk and meet specific performance requirements. As a result, the share of the Others product segment rises steadily over the forecast period while coconut diethanolamide remains the dominant product type.
Sustainability and Traceability Requirements
Consumer goods companies have set targets for deforestation-free and traceable oleochemical supply chains, and the European Union has adopted a regulation on deforestation-free products covering palm oil and its derivatives. Diethanolamide producers face growing requirements for supply chain certification, mass-balance documentation and product carbon footprint data, which raise compliance costs but also differentiate suppliers with robust sourcing programmes.
Managing Nitrosamine Risk Across the Value Chain
Controlling residual diethanolamine and avoiding contact with nitrosating agents remain technical challenges for producers and formulators. Process optimisation, improved raw material specifications and analytical testing for nitrosamines are becoming standard expectations, particularly for customers in regulated cosmetic and metalworking fluid markets.
The diethanolamide value chain links two distinct feedstock chains, lauric oils and petrochemical ethanolamines, with formulators of consumer and industrial products. Value is added at each stage through processing, quality control, technical service and logistics.
Raw materials and inputs. The fatty component is supplied as coconut oil, palm kernel oil or other vegetable oils, or as their derived fatty acids and fatty acid methyl esters. Coconut oil is produced mainly in the Philippines, Indonesia and India, while palm kernel oil is produced mainly in Indonesia and Malaysia. Oleochemical producers split and fractionate these oils into C8–C18 fatty acid cuts or transesterify them into methyl esters. Diethanolamine is produced by reacting ethylene oxide with ammonia, a process operated by large petrochemical producers that co-produce monoethanolamine and triethanolamine. Catalysts such as sodium methoxide and utilities complete the input base.
Manufacturing. Diethanolamides are made by batch condensation of the fatty feedstock with diethanolamine. The 1:1 superamide route reacts methyl esters with diethanolamine at moderate temperature with removal of methanol, whereas the 2:1 Kritchevsky route reacts fatty acids with excess diethanolamine and removes water. Process control of temperature, stoichiometry and reaction time determines amide content, free amine, ester by-products and colour. Producers range from integrated oleochemical groups and multinational surfactant manufacturers to regional specialty chemical companies and toll manufacturers.
Distribution and channels. Large personal care and home care multinationals purchase directly from producers under annual or multi-year supply agreements. Small and medium formulators, contract manufacturers and industrial users are served through chemical distributors that provide warehousing, repackaging, small-lot supply and local technical support. Products are shipped in drums, intermediate bulk containers and bulk tankers.
End users. Diethanolamides are incorporated into shampoos, body washes, liquid hand soaps and bath products in personal care; hand dishwashing liquids, all-purpose cleaners and liquid detergents in household cleaning; and metalworking fluids, textile auxiliaries, industrial and institutional cleaners, agrochemical formulations and other specialty products in industrial and other applications.
Diethanolamides are regulated primarily through cosmetic ingredient rules, chemical hazard communication and carcinogen listings, reflecting concerns over residual diethanolamine and the potential formation of N-nitrosodiethanolamine. Requirements are most stringent in North America and Europe, while regulatory frameworks in Asia Pacific, Latin America and the Middle East & Africa focus on ingredient inventories, registration and product safety.
North America
California Proposition 65: The Office of Environmental Health Hazard Assessment listed coconut oil diethanolamine condensate (cocamide diethanolamine) as a chemical known to the State to cause cancer on 22 June 2012; diethanolamine was listed on the same date. Products sold in California that expose consumers to these substances require a clear and reasonable warning.
U.S. Food and Drug Administration: FDA does not specifically restrict diethanolamine or DEA-related ingredients such as cocamide DEA and lauramide DEA in cosmetics, but has noted that their use has declined. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduced facility registration, product and ingredient listing, safety substantiation and adverse event reporting requirements that increase documentation obligations for formulators using diethanolamides.
U.S. National Toxicology Program: NTP Technical Report 479 (2001) on coconut oil acid diethanolamine condensate found clear evidence of carcinogenic activity in mice in dermal studies and attributed the effects to free diethanolamine present in the test material, a finding that continues to inform risk assessments.
Canada: Diethanolamine and nitrosamines are prohibited in cosmetics under Health Canada's Cosmetic Ingredient Hotlist. Coconut diethanolamide and lauramide DEA were assessed in the Alkanolamines and Fatty Alkanolamides Group under the Chemicals Management Plan; the final assessment published in June 2026 concluded that the substances are not harmful at current exposure levels, and the government proposed applying Significant New Activity provisions and adding them to its Watch List.
Europe
EU Cosmetics Regulation (EC) No 1223/2009: Fatty acid dialkylamides and dialkanolamides, including cocamide DEA, are restricted under Annex III, with a maximum secondary amine content of 0.5% in the finished product and 5% in raw materials, a maximum nitrosamine content of 50 µg/kg, a prohibition on use with nitrosating systems and a requirement to keep the substances in nitrite-free containers. Secondary alkyl- and alkanolamines and their salts, including diethanolamine, are prohibited under Annex II.
REACH and CLP: Substances manufactured in or imported into the EU are subject to registration under REACH (Regulation (EC) No 1907/2006). Cocamide DEA has no harmonised classification under CLP, and industry notifications commonly classify it as a skin irritant and as causing serious eye damage.
EU Detergents Regulation: Regulation (EC) No 648/2004 requires surfactants in detergents to meet ultimate aerobic biodegradability criteria. It will be replaced by Regulation (EU) 2026/405 on detergents and surfactants, which entered into force in March 2026 and applies from September 2029, retaining surfactant biodegradability requirements and adding digital labelling provisions.
United Kingdom: Following its exit from the EU, the U.K. operates UK REACH and its own cosmetics regulation, which retain the restrictions inherited from EU law.
Asia Pacific
China: The Cosmetics Supervision and Administration Regulation (CSAR), in force since 1 January 2021 and administered by the National Medical Products Administration, requires cosmetic ingredients to appear on the Inventory of Existing Cosmetic Ingredients in China and strengthens safety assessment and product registration requirements.
India: The Bureau of Indian Standards publishes IS 7101 (Coconut Diethanolamide for Cosmetic Industry – Specification), which sets quality requirements for the product, and cosmetics are regulated under the Cosmetics Rules, 2020.
Japan: Coconut fatty acid diethanolamide is managed as a general chemical substance under the Chemical Substances Control Law.
Australia: The former National Industrial Chemicals Notification and Assessment Scheme assessed diethanolamine in 2013, noting that it can occur as a contaminant of fatty acid diethanolamide surfactants; diethanolamine is controlled under the Poisons Standard.
Latin America and Middle East & Africa
Brazil: The national health surveillance agency ANVISA regulates cosmetic and sanitising products and maintains lists of restricted and prohibited cosmetic substances that are broadly aligned with international practice.
Gulf Cooperation Council: GCC technical regulations for cosmetic products, implemented by national authorities such as the Saudi Food and Drug Authority, draw on internationally recognised lists of prohibited and restricted ingredients.
The table below summarises key strategic developments by leading companies since 2022.
Jan 2022: Evonik Industries; Partnership; Entered an exclusive partnership with Unilever to introduce rhamnolipid biosurfactants in Unilever hand dishwashing brands.
Apr 2022: Indorama Ventures; Acquisition; Completed the acquisition of Oxiteno from Ultrapar, adding surfactant plants in Brazil, the U.S., Mexico and Uruguay.
Jul 2022: Croda International; Divestment; Completed the sale of most of its Performance Technologies and Industrial Chemicals business to Cargill.
Jul 2022: Innospec Inc.; Expansion; Acquired land adjacent to its Salisbury, North Carolina personal care plant and added capacity backed by multi-year contracts.
Sep 2022: Stepan Company; Acquisition; Agreed to acquire the surfactant business and assets of PerformanX Specialty Chemicals.
Sep 2022: Kao Corporation; Partnership; Joined Geno and Unilever as a founding member of a venture to scale plant-based alternatives to palm kernel oil.
Apr 2023: KLK OLEO; Acquisition; Completed the acquisition of a controlling stake in Temix Oleo, an Italian ester producer.
Apr 2023: KLK OLEO; Expansion; Broke ground on a new site at West Port 2, Malaysia, for additional fatty alcohol and fatty acid capacity.
Jun 2023: BASF SE; Expansion; Began expanding alkoxylation capacity in Antwerp and Ludwigshafen by more than 150,000 metric tons per year.
Jul 2023: Evonik Industries; Acquisition; Acquired Novachem, an Argentine cosmetic actives company, for its Care Solutions business.
Jul 2023: Croda International; Acquisition; Completed the acquisition of Solus Biotech, a Korean producer of ceramides and actives.
Dec 2023: Innospec Inc.; Acquisition; Completed the acquisition of QGP Química Geral in Brazil, adding surfactant chemistries to Performance Chemicals.
Dec 2023: Syensqo SA; Divestment; Separated from Solvay and listed as an independent specialty materials company.
May 2024: Evonik Industries; Expansion; Opened an industrial-scale rhamnolipid biosurfactant plant in Slovenská Ľupča, Slovakia.
Jul 2024: KLK OLEO; Expansion; Opened a high-purity fatty acids and glycerine plant in Zhangjiagang, China.
Nov 2024: Indorama Ventures; Acquisition; Agreed to acquire Cargill's KEMELIX and FLOWSOLVE specialty surfactant brands and a Houston R&D facility.
Mar 2025: Galaxy Surfactants; Partnership; Agreed with a global customer to engineer and build an overseas performance surfactants plant.
Apr 2025: Stepan Company; Expansion; Started up a new 75,000 metric tons per year alkoxylation plant in Pasadena, Texas.
Aug 2025: Kao Corporation; Expansion; Opened a 20,000 metric tons per year tertiary amine plant in Pasadena, Texas.
Nov 2025: BASF SE; Expansion; Opened a new alkyl polyglucoside surfactant plant in Bangpakong, Thailand.
Jan 2026: Syensqo SA; Divestment; Completed the sale of its Oil & Gas business unit to SNF Group.
Feb 2026: Syensqo SA; Product Launch; Launched Rhodasurf B7 UP, a bio-circular laureth-7 surfactant produced at Moerdijk, the Netherlands.
Mar 2026: Croda International; Expansion; Opened a new manufacturing facility in Dahej, India, using RSPO-certified oleochemicals.
Jul 2026: Galaxy Surfactants; Partnership; Appointed DKSH as exclusive distributor of its specialty personal care ingredients in 16 European markets.
Aug 2026: Galaxy Surfactants; Partnership; Signed a partnership charter with Unilever covering next-generation and bio-based surfactants.
Political
Export and biodiesel policies in Indonesia and Malaysia influence the availability and price of palm kernel oil, the main alternative lauric feedstock.
Agricultural development programmes for coconut replanting in the Philippines, Indonesia and India affect long-term coconut oil supply.
Trade policy, including tariffs on chemical imports among major economies, alters sourcing decisions for surfactant intermediates.
Economic
Household spending on personal care and cleaning products drives demand, with value-tier products in emerging markets the main growth engine.
Coconut oil reached record prices in 2025, increasing cost pressure on coconut diethanolamide producers.
Ethylene oxide and energy costs feed through to diethanolamine prices and producer margins.
Social
Urbanisation and the shift from bar soaps and powders to liquid formats increase the use of foam boosters and thickeners.
Consumer awareness of ingredient safety, amplified by "free-from" marketing, reduces acceptance of DEA-derived ingredients in premium personal care.
Sustained hygiene awareness supports consumption of hand soaps and household cleaners.
Technological
Improved methyl ester-based superamide processes yield lower free amine and lower nitrosamine potential.
Analytical advances allow routine testing for nitrosamines and residual diethanolamine at low concentrations.
Development of alternative mild surfactants and polymeric thickeners provides substitution options for formulators.
Environmental
Requirements for deforestation-free, traceable palm and coconut supply chains are increasing for oleochemical producers.
Biodegradability requirements for surfactants used in detergents shape product acceptance in household cleaning.
Aquatic toxicity classifications influence labelling and wastewater management for formulators.
Legal
California Proposition 65 warning requirements apply to products containing coconut oil diethanolamine condensate.
EU cosmetic restrictions on fatty acid dialkanolamides set limits on secondary amine and nitrosamine content.
Chemical registration regimes, such as REACH in the EU and inventory requirements in the U.S., China and other countries, impose data and compliance obligations on producers and importers.
Profiles of 104 companies operating in the Diethanolamide Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Company Headquarters: Illinois, US Founded: 1932 Workforce: ~2,250 Company Working: Stepan Company (Stepan) is engaged in the manufacturing and sale of specialty and intermediate chemicals. It operates through the segments, namely surfactants, polymers, and specialty products. Surfactants segment offers oilfield biocides along with a wide range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants. The polymers segment produces polyester polyols and phthalic anhydride. The specialty products are chemicals used in food, flavoring, nutritional supplement, and pharmaceutical applications.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
3 interactive charts drawn from the Diethanolamide Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Diethanolamide Market By Application
Global Diethanolamide Market By Product Type
Global Diethanolamide Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
